Virtu Financial LLC Has $291,000 Stake in BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Virtu Financial LLC boosted its position in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 71.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,857 shares of the company’s stock after acquiring an additional 8,256 shares during the quarter. Virtu Financial LLC’s holdings in BlackRock Health Sciences Term Trust were worth $291,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Benjamin F. Edwards & Company Inc. lifted its position in shares of BlackRock Health Sciences Term Trust by 24.1% in the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 4,792 shares of the company’s stock valued at $70,000 after buying an additional 930 shares during the last quarter. Stratos Wealth Advisors LLC acquired a new stake in BlackRock Health Sciences Term Trust during the 4th quarter valued at $170,000. CWM LLC boosted its position in BlackRock Health Sciences Term Trust by 1,212,300.0% during the fourth quarter. CWM LLC now owns 12,124 shares of the company’s stock worth $178,000 after purchasing an additional 12,123 shares during the period. Pine Valley Investments Ltd Liability Co increased its holdings in shares of BlackRock Health Sciences Term Trust by 6.7% in the fourth quarter. Pine Valley Investments Ltd Liability Co now owns 13,088 shares of the company’s stock valued at $192,000 after purchasing an additional 822 shares during the last quarter. Finally, B. Riley Wealth Advisors Inc. raised its position in shares of BlackRock Health Sciences Term Trust by 4.8% in the third quarter. B. Riley Wealth Advisors Inc. now owns 17,363 shares of the company’s stock valued at $250,000 after purchasing an additional 796 shares during the period.

Insider Activity

In other news, major shareholder Saba Capital Management, L.P. purchased 16,297 shares of BlackRock Health Sciences Term Trust stock in a transaction that occurred on Thursday, March 28th. The stock was acquired at an average cost of 16.33 per share, for a total transaction of 266,130.01. Following the purchase, the insider now directly owns 20,492,010 shares of the company’s stock, valued at approximately 334,634,523.30. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Over the last quarter, insiders have bought 192,090 shares of company stock valued at $3,135,536.

BlackRock Health Sciences Term Trust Stock Performance

NYSE BMEZ opened at 14.90 on Friday. BlackRock Health Sciences Term Trust has a 52-week low of 12.93 and a 52-week high of 16.59. The firm has a 50-day moving average of 15.07 and a 200-day moving average of 15.34.

BlackRock Health Sciences Term Trust Increases Dividend

The company also recently disclosed a monthly dividend, which will be paid on Friday, June 28th. Stockholders of record on Friday, June 14th will be issued a dividend of $0.179 per share. This represents a $2.15 dividend on an annualized basis and a dividend yield of 14.42%. The ex-dividend date of this dividend is Friday, June 14th. This is a boost from BlackRock Health Sciences Term Trust’s previous monthly dividend of $0.09.

BlackRock Health Sciences Term Trust Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.